Does Angioedema Cause Pain? A Comprehensive Guide to Symptoms, Causes, and Treatment

Angioedema is a condition characterized by sudden, localized swelling beneath the skin or mucous membranes. While often associated with visible swelling, particularly of the face, lips, and extremities, a common question many individuals and caregivers ask is: “Does angioedema cause pain?” The answer is a resounding yes. Angioedema can indeed be a source of significant discomfort, ranging from a dull ache and pressure to severe, debilitating pain, especially when internal organs like the gastrointestinal tract are affected. Understanding the nuances of angioedema, its various forms, and how it manifests with pain is crucial for accurate diagnosis, effective management, and improving the quality of life for those affected.

This comprehensive guide will delve into the types of pain associated with angioedema, explore the diverse causes behind this often perplexing condition, detail its wide array of symptoms, and outline the diagnostic processes, treatment options, and preventive strategies available. We will also address when it’s critical to seek medical attention and answer some frequently asked questions to provide a holistic understanding of angioedema and its painful dimension.

Understanding Angioedema: More Than Just Swelling

Angioedema is a distinct form of swelling that occurs in the deeper layers of the skin, typically the dermis and subcutaneous tissues, or in the submucosal layers of the respiratory and gastrointestinal tracts. Unlike urticaria (hives), which manifests as itchy, red, superficial welts, angioedema presents as a deeper, often non-itchy, and sometimes painful swelling. While urticaria and angioedema can occur together, they are distinct phenomena.

The Role of Chemical Mediators: Histamine vs. Bradykinin

The underlying mechanism of angioedema involves the release of certain chemical mediators that increase vascular permeability, allowing fluid to leak from blood vessels into surrounding tissues. The two primary mediators responsible for different types of angioedema are histamine and bradykinin.

• Histamine-Mediated Angioedema: This type is often triggered by allergic reactions or is associated with chronic urticaria. Histamine, released from mast cells, causes vasodilation and increased permeability. This form is typically responsive to antihistamines and corticosteroids.
• Bradykinin-Mediated Angioedema: This form is not allergic and does not respond to antihistamines or corticosteroids. Bradykinin is a potent vasodilator that increases vascular permeability. Its uncontrolled production or breakdown leads to swelling. This type is characteristic of hereditary angioedema (HAE), acquired angioedema (AAE), and ACE inhibitor-induced angioedema.

The distinction between histamine and bradykinin-mediated angioedema is paramount for correct diagnosis and treatment, as the therapeutic approaches differ significantly.

Does Angioedema Cause Pain? Delving into the Discomfort

The short answer is unequivocally yes, angioedema can cause pain. The pain experienced by individuals with angioedema can vary greatly in intensity, character, and location, depending on where the swelling occurs and the underlying cause. It's not just a feeling of tightness or pressure; for many, it can be a genuinely painful experience.

Types and Locations of Angioedema Pain:

• Skin Swelling Pain: When angioedema affects the skin, particularly around the face, lips, eyelids, hands, feet, or genitals, the swelling itself can exert pressure on nerve endings, leading to a dull ache, a feeling of tightness, or a burning sensation. The skin may feel stretched and tender to the touch. In severe cases, the sheer volume of swelling can be excruciatingly painful, making movement difficult and even distorting facial features.
• Gastrointestinal (GI) Pain: This is one of the most common and often most severe forms of pain associated with angioedema, particularly in bradykinin-mediated forms like HAE. Swelling in the walls of the intestines can cause intense, cramp-like abdominal pain, often described as excruciating. This pain can mimic acute surgical emergencies like appendicitis or bowel obstruction, leading to unnecessary surgeries if angioedema is not recognized. Patients may also experience nausea, vomiting, and diarrhea, further contributing to their distress. The pain can be so severe that it incapacitates individuals, requiring strong pain management.
• Respiratory Tract Pain/Discomfort: Swelling in the larynx (voice box) or pharynx (throat) is life-threatening and can cause a sensation of choking, difficulty swallowing (dysphagia), and hoarseness. While not typically described as pain in the traditional sense, the intense discomfort, feeling of suffocation, and extreme anxiety associated with airway obstruction are profoundly distressing and can be perceived as a form of agony.
• Muscle and Joint Pain: In some cases, swelling can extend to muscles or joints, leading to a feeling of stiffness, restricted movement, and localized pain. This is less common than cutaneous or GI involvement but can still contribute to overall discomfort.

The pain associated with angioedema is not merely a secondary symptom; it is a primary and often debilitating feature of the condition, significantly impacting a patient's quality of life and requiring specific attention in treatment plans.

Symptoms of Angioedema: Beyond Visible Swelling

While swelling is the hallmark symptom, angioedema can present with a wide range of manifestations, some of which are less obvious but equally, if not more, dangerous. Recognizing the full spectrum of symptoms is crucial for prompt diagnosis and intervention.

1. Skin Swelling (Cutaneous Angioedema):

• Appearance: Deep-seated, localized swelling that often affects the face (lips, eyelids), tongue, hands, feet, and genitals. Unlike hives, it typically does not itch, but may feel tight, warm, or painful.
• Texture: The affected area may feel firm or rubbery to the touch. The skin may appear pale or normal in color, rather than red like hives.
• Duration: Swelling can develop rapidly over minutes to hours and usually resolves within 24 to 72 hours, though it can sometimes last longer.
• Impact: Swelling can be disfiguring, causing significant distress and interfering with daily activities, such as eating, speaking, or walking.

2. Gastrointestinal Symptoms (Abdominal Angioedema):

• Severe Abdominal Pain: This is a common and often excruciating symptom, especially in bradykinin-mediated angioedema. The pain is typically cramp-like, diffuse, and can be so intense that it mimics an acute surgical abdomen.
• Nausea and Vomiting: Frequent companions to abdominal pain, these can lead to dehydration and further discomfort.
• Diarrhea: Also a common symptom, sometimes severe.
• Ascites: In some cases, fluid accumulation in the abdominal cavity can occur, leading to distension.
• Misdiagnosis Risk: Due to the severity and nature of the pain, abdominal angioedema is frequently misdiagnosed as appendicitis, cholecystitis, or other acute abdominal conditions, leading to unnecessary exploratory surgeries.

3. Respiratory Symptoms (Laryngeal/Pharyngeal Angioedema):

• Hoarseness: A change in voice quality due to swelling of the vocal cords.
• Stridor: A high-pitched, harsh sound during breathing, indicating airway narrowing.
• Dysphagia: Difficulty swallowing.
• Dyspnea: Shortness of breath or difficulty breathing.
• Choking Sensation: A terrifying feeling of the throat closing, which can progress rapidly.
• Life-Threatening Risk: Swelling of the larynx or pharynx can lead to complete airway obstruction and asphyxiation, making this a medical emergency requiring immediate intervention.

4. Other Symptoms:

• Fatigue and Malaise: A general feeling of being unwell, often preceding or accompanying an attack.
• Headache: Some individuals report headaches during angioedema episodes.
• Anxiety: The unpredictable nature of attacks, especially the risk of airway involvement, can cause significant anxiety and psychological distress.
• Prodromal Symptoms: In some forms, particularly hereditary angioedema, patients may experience warning signs hours or days before a full-blown attack. These can include a tingling sensation, a non-itchy rash known as erythema marginatum (a serpiginous, non-pruritic, erythematous rash), or a general feeling of unease.

Causes of Angioedema: A Complex Web

The etiology of angioedema is diverse, broadly categorized into histamine-mediated and bradykinin-mediated forms, each with distinct triggers and underlying mechanisms.

A. Histamine-Mediated Angioedema:

This is the more common type and is typically associated with allergic reactions or chronic urticaria. It involves the release of histamine from mast cells and basophils.

1. Allergic Angioedema: Triggered by exposure to specific allergens.
   • Foods: Peanuts, tree nuts, shellfish, milk, eggs, soy, wheat are common culprits.
   • Drugs: Antibiotics (especially penicillin), NSAIDs (non-steroidal anti-inflammatory drugs like ibuprofen, aspirin), contrast dyes, and opioids can induce allergic reactions.
   • Insect Stings: Bee, wasp, hornet stings.
   • Latex: Contact with latex products.
   • Mechanism: An IgE-mediated immune response leads to mast cell degranulation and histamine release. This form can be part of anaphylaxis, a severe, life-threatening allergic reaction.
2. Acute Urticaria and Angioedema: Episodes lasting less than six weeks. Often triggered by infections (viral, bacterial), drugs, or foods.
3. Chronic Spontaneous Urticaria (CSU) and Angioedema: Episodes occurring most days of the week for more than six weeks, without an identifiable external trigger. It’s often autoimmune, where the body produces antibodies against its own mast cells or IgE receptors.
4. Physical Urticarias and Angioedema: Triggered by specific physical stimuli such as cold (cold urticaria), pressure (delayed pressure urticaria), heat, sun exposure (solar urticaria), or vibration.

B. Bradykinin-Mediated Angioedema:

This form is characterized by the overproduction or impaired breakdown of bradykinin, leading to fluid leakage. It does not respond to antihistamines or corticosteroids and requires specific treatments.

1. Hereditary Angioedema (HAE): A rare genetic disorder caused by a deficiency or dysfunction of C1 esterase inhibitor (C1-INH), a protein that regulates the complement system and bradykinin pathway. Inheritance is autosomal dominant.
   • HAE Type I: Accounts for about 85% of HAE cases. Characterized by low levels of functional C1-INH protein.
   • HAE Type II: Accounts for about 15% of HAE cases. Characterized by normal or elevated levels of C1-INH protein, but the protein is dysfunctional.
   • HAE with Normal C1-INH (formerly Type III): This rarer form primarily affects women and is sometimes linked to mutations in the Factor XII gene (F12). Other genetic mutations (e.g., plasminogen, angiopoietin-1) have been identified, and many cases remain idiopathic. Estrogen, pregnancy, and oral contraceptives can exacerbate attacks.
   • Triggers for HAE Attacks: Stress, trauma (including dental procedures), infections, certain medications (estrogens), and sometimes no apparent trigger.
2. Acquired Angioedema (AAE): Also rare, AAE typically develops in adulthood and is associated with other underlying medical conditions. It results from a consumption or destruction of C1-INH.
   • AAE Type I: Associated with lymphoproliferative disorders (e.g., lymphoma, leukemia) or autoimmune diseases (e.g., lupus). These conditions can lead to the consumption of C1-INH.
   • AAE Type II: Characterized by autoantibodies that attack and inactivate C1-INH.
3. ACE Inhibitor-Induced Angioedema (ACEi-AAE): This is the most common form of bradykinin-mediated angioedema. It’s a side effect of angiotensin-converting enzyme (ACE) inhibitor medications, which are widely used to treat high blood pressure and heart failure (e.g., lisinopril, enalapril).
   • Mechanism: ACE inhibitors block the enzyme that degrades bradykinin, leading to its accumulation and subsequent swelling.
   • Onset: Can occur at any time during treatment, from days to years after starting the medication.
   • Risk Factors: African American ethnicity, older age, smoking, history of seasonal allergies.
4. Other Drug-Induced Angioedema: Less common but other medications, such as angiotensin receptor blockers (ARBs, e.g., valsartan), dipeptidyl peptidase-4 (DPP-4) inhibitors (gliptins, e.g., sitagliptin), and thrombolytics, have been reported to cause bradykinin-mediated angioedema.

Diagnosis of Angioedema: Pinpointing the Type

Accurate diagnosis is paramount because the treatment strategies for histamine-mediated and bradykinin-mediated angioedema are vastly different. A thorough medical history, physical examination, and specific laboratory tests are essential.

1. Clinical History and Physical Examination:

• Detailed Symptom Description: Nature of swelling (itchy vs. non-itchy, painful vs. painless), location, duration, frequency, and severity of attacks.
• Triggers: Inquiry about potential allergens (foods, drugs, insect stings), physical stimuli, stress, recent infections, or dental procedures.
• Medication Review: Crucial to identify current or past use of ACE inhibitors, NSAIDs, or other relevant drugs.
• Family History: Essential for suspecting hereditary angioedema.
• Review of Systems: To identify associated conditions (e.g., autoimmune diseases, lymphoproliferative disorders).

2. Laboratory Tests:

These tests help differentiate between the various types of angioedema.

• Complement System Evaluation: These tests are critical for diagnosing HAE and AAE.
  • C4 Level: A screening test. Low C4 levels are often found in both HAE (Type I and II) and AAE. During an attack, C4 levels are typically very low.
  • C1 Esterase Inhibitor (C1-INH) Quantitative Level: Measures the amount of C1-INH protein in the blood. Low levels indicate HAE Type I or AAE.
  • C1 Esterase Inhibitor (C1-INH) Functional Level: Measures how well the C1-INH protein is working. Low functional levels, even with normal quantitative levels, indicate HAE Type II or AAE.
  • C1q Level: This test helps differentiate HAE from AAE. C1q levels are typically normal in HAE but low in AAE (due to its consumption in underlying conditions).
• Allergy Testing: If histamine-mediated angioedema is suspected.
  • Specific IgE Blood Tests: To identify antibodies to specific allergens.
  • Skin Prick Tests: To assess immediate allergic reactions.
• Other Tests:
  • Thyroid Function Tests: To rule out thyroid disorders, which can sometimes be associated with angioedema.
  • Autoimmune Markers: Such as antinuclear antibodies (ANA) if an autoimmune disease is suspected as an underlying cause for AAE.
  • Complete Blood Count (CBC) and ESR/CRP: To look for signs of infection, inflammation, or underlying hematological disorders.
  • Genetic Testing: For HAE with normal C1-INH, genetic testing for F12 or other identified mutations may be performed.

3. Differential Diagnosis:

It’s important to distinguish angioedema from other conditions that cause swelling, such as:

• Anaphylaxis (usually with hives, itching, and rapid progression to shock).
• Cellulitis (bacterial skin infection, often painful, red, warm, with fever).
• Deep vein thrombosis (DVT) (unilateral leg swelling, pain).
• Superior vena cava syndrome (swelling of face, neck, upper chest).
• Thyroid eye disease (periorbital swelling).
• Lymphatic obstruction.

Treatment Options for Angioedema: Managing Attacks and Preventing Future Episodes

Treatment for angioedema is highly dependent on its underlying cause and severity. It focuses on managing acute attacks, preventing future episodes, and addressing any underlying conditions.

A. Acute Attack Treatment:

Rapid intervention is crucial, especially for laryngeal swelling or severe abdominal pain. Treatment differs significantly between histamine-mediated and bradykinin-mediated angioedema.

1. For Histamine-Mediated Angioedema (e.g., allergic, chronic spontaneous):
   • Antihistamines: H1 antihistamines (e.g., cetirizine, fexofenadine, hydroxyzine) are the first line. H2 antihistamines (e.g., ranitidine, famotidine) may be added for refractory cases.
   • Corticosteroids: (e.g., prednisone, methylprednisolone) help reduce inflammation and swelling.
   • Epinephrine (Adrenaline): Administered via auto-injector (e.g., EpiPen) in cases of anaphylaxis or rapidly progressing airway swelling. This is a life-saving medication.
   • Airway Management: In severe laryngeal edema, intubation or tracheostomy may be necessary to secure the airway.
2. For Bradykinin-Mediated Angioedema (HAE, AAE, ACEi-AAE): These do NOT respond to antihistamines or corticosteroids. Specific bradykinin-pathway targeted therapies are required.
   • C1 Esterase Inhibitor (C1-INH) Concentrate: Replenishes the deficient or dysfunctional C1-INH protein. Available as plasma-derived (e.g., Cinryze, Berinert) or recombinant (e.g., Ruconest) formulations. Administered intravenously.
   • Kallikrein Inhibitors:
     • Ecallantide (Kalbitor): Blocks plasma kallikrein, an enzyme upstream in the bradykinin pathway, thus reducing bradykinin production. Administered subcutaneously.
     • Lanadelumab (Takhzyro): A monoclonal antibody that targets plasma kallikrein. Used for prophylaxis, but can also be used for acute attacks in some protocols. Administered subcutaneously.
   • Bradykinin B2 Receptor Antagonist:
     • Icatibant (Firazyr): Blocks the bradykinin B2 receptor, preventing bradykinin from binding and causing swelling. Administered subcutaneously.
   • Supportive Care for ACEi-AAE: Discontinuation of the ACE inhibitor is paramount. No specific antidote exists, so treatment is largely supportive, including close monitoring of the airway and, if available, C1-INH concentrate or icatibant may be considered off-label, though evidence is limited.
   • Pain Management: For severe abdominal pain, opioid analgesics may be necessary, along with antiemetics for nausea and vomiting. NSAIDs should generally be avoided, especially in HAE, as they can sometimes exacerbate attacks.

B. Long-Term Prophylaxis (Prevention):

For individuals with recurrent or severe angioedema attacks, especially HAE or chronic spontaneous urticaria with angioedema, long-term prophylactic treatment may be recommended to reduce the frequency and severity of episodes.

1. For Histamine-Mediated Angioedema (Chronic Spontaneous Urticaria with Angioedema):
   • High-Dose Antihistamines: Non-sedating H1 antihistamines at up to four times the standard dose.
   • Omalizumab (Xolair): A monoclonal antibody that targets IgE, used for refractory chronic spontaneous urticaria and angioedema. Administered subcutaneously.
   • Corticosteroids: Used sparingly for short courses due to side effects, but sometimes necessary for severe flares.
   • Immunosuppressants: Cyclosporine or other agents for very severe, refractory cases.
2. For Bradykinin-Mediated Angioedema (HAE/AAE):
   • Long-Term C1-INH Concentrate: Regular intravenous infusions of C1-INH concentrate (e.g., Cinryze, Haegarda) to maintain adequate levels and prevent attacks.
   • Kallikrein Inhibitors: Lanadelumab (Takhzyro) is approved for long-term prophylaxis of HAE, significantly reducing attack frequency.
   • Androgens: Attenuated androgens (e.g., danazol, stanozolol) increase C1-INH production in the liver. These are older treatments with significant side effects (virilization, liver toxicity) and are generally reserved for situations where newer therapies are unavailable or contraindicated.
   • Antifibrinolytics: (e.g., tranexamic acid, epsilon-aminocaproic acid) can be used, particularly in milder cases or as an adjunct, though less effective than C1-INH or kallikrein inhibitors.

Prevention: Minimizing Risk and Triggers

While not all angioedema attacks can be prevented, especially in genetic forms, certain strategies can significantly reduce the risk and severity of episodes.

• Trigger Avoidance: Identifying and rigorously avoiding known triggers is paramount. This includes specific food allergens, certain medications (especially ACE inhibitors if you have a history of angioedema), insect stings, or physical stimuli.
• Medication Review: Regularly review all medications with your doctor to ensure none are contributing to your angioedema. Never stop prescribed medications without consulting your physician.
• Stress Management: Stress is a known trigger for many types of angioedema, including HAE and chronic spontaneous urticaria. Incorporating stress-reduction techniques like meditation, yoga, mindfulness, or regular exercise can be beneficial.
• Pre-Procedure Prophylaxis: For individuals with HAE or AAE, specific prophylaxis with C1-INH concentrate or other medications may be necessary before dental procedures, surgeries, or any procedure that could induce trauma and trigger an attack.
• Regular Medical Follow-ups: Consistent communication with an allergist/immunologist or a specialist experienced in angioedema is crucial for monitoring the condition, adjusting treatment plans, and staying informed about new therapies.
• Emergency Action Plan: All patients with a history of severe angioedema, especially those with airway involvement risk, should have a personalized emergency action plan. This includes carrying emergency medications (e.g., epinephrine auto-injector for allergic angioedema, specific HAE medications) and clear instructions for family members and emergency responders.
• Medical Alert Identification: Wearing a medical alert bracelet or carrying an identification card detailing your condition (e.g., Hereditary Angioedema) and emergency contacts can be life-saving.

When to See a Doctor: Recognizing Warning Signs

Knowing when to seek medical attention is vital for anyone experiencing angioedema, as some forms can be life-threatening. Do not hesitate to seek immediate medical care if you experience any of the following:

• Sudden, Severe, or Rapidly Worsening Swelling: Especially if it affects the face, lips, tongue, or throat.
• Difficulty Breathing, Swallowing, or Speaking: These are signs of potential airway compromise and constitute a medical emergency. Call emergency services immediately.
• Severe Abdominal Pain: Particularly if accompanied by nausea, vomiting, or dehydration, as this can indicate intestinal swelling and severe distress.
• Any New or Unexplained Swelling: If you develop swelling that you've never experienced before, or if it differs from your usual episodes.
• Known Angioedema with Worsening Symptoms: If your usual angioedema attack is more severe than typical, or if your prescribed emergency medications are not providing relief.
• Fever or Signs of Infection: If swelling is accompanied by redness, warmth, pus, or fever, it could indicate cellulitis or another infection requiring different treatment.
• Swelling After Starting a New Medication: Especially if you've recently started an ACE inhibitor.

Early recognition and prompt medical intervention can prevent serious complications and ensure appropriate treatment.

Living with Angioedema: Daily Management and Support

Living with angioedema, particularly recurrent or severe forms, can be challenging. It requires proactive management, patient education, and a strong support system.

• Patient Education: Understanding your specific type of angioedema, its triggers, symptoms, and treatment options empowers you to manage your condition effectively.
• Support Groups: Connecting with others who have angioedema can provide emotional support, practical advice, and a sense of community. Organizations dedicated to HAE, for instance, offer valuable resources.
• Medical Identification: Always carry documentation of your condition and emergency contact information. A medical alert bracelet or necklace can speak for you in an emergency.
• Mental Health Support: The unpredictable nature of angioedema and the fear of life-threatening attacks can lead to anxiety, depression, and significant stress. Seeking support from mental health professionals can be beneficial.

FAQs (Frequently Asked Questions)

Q1: Is angioedema life-threatening?

A1: Yes, angioedema can be life-threatening, especially if it involves the larynx (voice box) or pharynx (throat), leading to airway obstruction and suffocation. Severe abdominal swelling can also lead to significant dehydration and pain that requires emergency care. Hereditary angioedema (HAE) and ACE inhibitor-induced angioedema are particularly associated with a higher risk of life-threatening airway swelling.

Q2: Can angioedema be cured?

A2: For most types of angioedema, there is no definitive "cure," but it can be effectively managed. Allergic angioedema can be prevented by strict avoidance of triggers. Hereditary angioedema (HAE) is a lifelong genetic condition, but modern therapies offer excellent control of attacks and prevention. Acquired angioedema (AAE) may improve if the underlying condition (e.g., lymphoma) is successfully treated.

Q3: What is the difference between angioedema and hives?

A3: While often occurring together, angioedema and hives (urticaria) are distinct. Hives are superficial, itchy, red welts on the skin's surface. Angioedema is deeper swelling in the dermis and subcutaneous tissues or mucous membranes, typically non-itchy but often painful, tight, or burning. Angioedema can affect internal organs, which hives generally do not.

Q4: Are there natural remedies for angioedema?

A4: There is no scientific evidence to support natural remedies as effective treatments for angioedema, especially for severe or bradykinin-mediated forms. Relying solely on unproven remedies can be dangerous, particularly in life-threatening situations. Always consult a healthcare professional for diagnosis and treatment. While some individuals find certain supplements (e.g., quercetin, vitamin C) helpful for general immune support or inflammation, these should never replace prescribed medical treatments.

Q5: Can stress cause angioedema?

A5: Yes, stress is a well-known trigger or exacerbating factor for various forms of angioedema, including hereditary angioedema (HAE) and chronic spontaneous urticaria with angioedema. Managing stress through relaxation techniques, mindfulness, and lifestyle adjustments can be an important part of a comprehensive management plan.

Q6: How long does an angioedema attack last?

A6: The duration of an angioedema attack can vary. Typically, swelling develops over minutes to hours and resolves within 24 to 72 hours. However, some attacks, especially in hereditary angioedema, can last for several days without treatment.

Q7: Is angioedema contagious?

A7: No, angioedema is not contagious. It is an internal physiological response to various triggers, not an infection that can spread from person to person.

Conclusion

Angioedema is a complex condition that, despite its varied presentations, frequently causes significant pain and discomfort, particularly when it affects the gastrointestinal tract or leads to severe skin swelling. Understanding whether angioedema causes pain and recognizing its diverse symptoms, from visible swelling to life-threatening airway compromise, is the first step toward effective management. With various causes ranging from allergic reactions to genetic predispositions and drug side effects, accurate diagnosis is the cornerstone of successful treatment. Modern medicine offers targeted therapies for both histamine-mediated and bradykinin-mediated forms, providing relief during acute attacks and preventing future episodes. By working closely with healthcare professionals, adhering to personalized treatment plans, avoiding known triggers, and having an emergency action plan, individuals living with angioedema can significantly improve their quality of life and minimize the impact of this challenging condition.

Sources / Medical References

• Healthline. (n.d.). Hereditary Angioedema: Does Angioedema Cause Pain? Retrieved from https://www.healthline.com/health/hereditary-angioedema/angioedema-cause-pain
• Cicardi, M., & Bork, K. (2021). Hereditary Angioedema (HAE): A Global View of the Disease. Springer.
• Longhurst, H. J., & Cicardi, M. (2012). Hereditary angio-oedema. The Lancet, 379(9814), 474-481.
• Maurer, M., Magerl, M., Ansotegui, I., Aygören-Pürsün, E., Betschel, S., Bork, K., ... & Zuberbier, T. (2018). The international WAO/EAACI guideline for the management of hereditary angioedema—The 2017 revision and update. Allergy, 73(6), 1184-1191.
• Kaplan, A. P., & Greaves, M. W. (2009). Angioedema. Journal of the American Academy of Dermatology, 60(1), 1-15.
• Gompels, M. M., Lock, R. J., Abinun, M., Bethune, C. A., Bowen, T., & British Society for Immunology Clinical Immunology Group. (2005). C1 inhibitor deficiency: consensus document. Clinical & Experimental Immunology, 139(3), 379-394.